United States Companion Diagnostics Market Report 2016

October 2016 | 119 pages | ID: UD52B6BF1D2EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Companion Diagnostics

Revenue, means the sales value of Companion Diagnostics

This report studies sales (consumption) of Companion Diagnostics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Roche Diagnostics (Switzerland)
• Abbott Laboratories (U.S.)
• Agilent Technologies (U.S.
• QIAGEN N.V. (Netherlands)
• Thermo Fisher Scientific Inc. (U.S.
• Myriad Genetics Inc. (U.S.)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Polymerase Chain Reaction Test ( PCR)
• Immunohistochemistry Test (IHC)
• In Situ Hybridization Test (ISH)
• Others

Split by applications, this report focuses on sales, market share and growth rate of Companion Diagnostics in each application, can be divided into

• Breast Cancer
• Non-small Cell Lung Cancer (NSCLC)
• Colorectal Cancer (CRC)
• Melanoma Cancer
• Gastric Cancer
• Others?

Contents

United States Companion Diagnostics Market Report 2016

1 COMPANION DIAGNOSTICS OVERVIEW

1.1 Product Overview and Scope of Companion Diagnostics
1.2 Classification of Companion Diagnostics
  1.2.1 Polymerase Chain Reaction Test ( PCR)
  1.2.2 Immunohistochemistry Test (IHC)
  1.2.3 In Situ Hybridization Test (ISH)
  1.2.4 Others
1.3 Application of Companion Diagnostics
  1.3.1 Breast Cancer
  1.3.2 Non-small Cell Lung Cancer (NSCLC)
  1.3.3 Colorectal Cancer (CRC)
  1.3.4 Melanoma Cancer
  1.3.5 Gastric Cancer
  1.3.6 Others?
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Companion Diagnostics (2011-2021)
  1.4.1 United States Companion Diagnostics Sales and Growth Rate (2011-2021)
  1.4.2 United States Companion Diagnostics Revenue and Growth Rate (2011-2021)

2 UNITED STATES COMPANION DIAGNOSTICS COMPETITION BY MANUFACTURERS

2.1 United States Companion Diagnostics Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Companion Diagnostics Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Companion Diagnostics Average Price by Manufactures (2015 and 2016)
2.4 Companion Diagnostics Market Competitive Situation and Trends
  2.4.1 Companion Diagnostics Market Concentration Rate
  2.4.2 Companion Diagnostics Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES COMPANION DIAGNOSTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Companion Diagnostics Sales and Market Share by Type (2011-2016)
3.2 United States Companion Diagnostics Revenue and Market Share by Type (2011-2016)
3.3 United States Companion Diagnostics Price by Type (2011-2016)
3.4 United States Companion Diagnostics Sales Growth Rate by Type (2011-2016)

4 UNITED STATES COMPANION DIAGNOSTICS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Companion Diagnostics Sales and Market Share by Application (2011-2016)
4.2 United States Companion Diagnostics Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES COMPANION DIAGNOSTICS MANUFACTURERS PROFILES/ANALYSIS

5.1 Roche Diagnostics (Switzerland)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Companion Diagnostics Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Roche Diagnostics (Switzerland) Companion Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Abbott Laboratories (U.S.)
  5.2.2 Companion Diagnostics Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Abbott Laboratories (U.S.) Companion Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Agilent Technologies (U.S.
  5.3.2 Companion Diagnostics Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Agilent Technologies (U.S. Companion Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 QIAGEN N.V. (Netherlands)
  5.4.2 Companion Diagnostics Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 QIAGEN N.V. (Netherlands) Companion Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Thermo Fisher Scientific Inc. (U.S.
  5.5.2 Companion Diagnostics Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Thermo Fisher Scientific Inc. (U.S. Companion Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Myriad Genetics Inc. (U.S.)
  5.6.2 Companion Diagnostics Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Myriad Genetics Inc. (U.S.) Companion Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview

6 COMPANION DIAGNOSTICS MANUFACTURING COST ANALYSIS

6.1 Companion Diagnostics Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Companion Diagnostics

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Companion Diagnostics Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Companion Diagnostics Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES COMPANION DIAGNOSTICS MARKET FORECAST (2016-2021)

10.1 United States Companion Diagnostics Sales, Revenue Forecast (2016-2021)
10.2 United States Companion Diagnostics Sales Forecast by Type (2016-2021)
10.3 United States Companion Diagnostics Sales Forecast by Application (2016-2021)
10.4 Companion Diagnostics Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Companion Diagnostics
Table Classification of Companion Diagnostics
Figure United States Sales Market Share of Companion Diagnostics by Type in 2015
Figure Polymerase Chain Reaction Test ( PCR) Picture
Figure Immunohistochemistry Test (IHC) Picture
Figure In Situ Hybridization Test (ISH) Picture
Figure Others Picture
Table Application of Companion Diagnostics
Figure United States Sales Market Share of Companion Diagnostics by Application in 2015
Figure Breast Cancer Examples
Figure Non-small Cell Lung Cancer (NSCLC) Examples
Figure Colorectal Cancer (CRC) Examples
Figure Melanoma Cancer Examples
Figure Gastric Cancer Examples
Figure Others? Examples
Figure United States Companion Diagnostics Sales and Growth Rate (2011-2021)
Figure United States Companion Diagnostics Revenue and Growth Rate (2011-2021)
Table United States Companion Diagnostics Sales of Key Manufacturers (2015 and 2016)
Table United States Companion Diagnostics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Companion Diagnostics Sales Share by Manufacturers
Figure 2016 Companion Diagnostics Sales Share by Manufacturers
Table United States Companion Diagnostics Revenue by Manufacturers (2015 and 2016)
Table United States Companion Diagnostics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Companion Diagnostics Revenue Share by Manufacturers
Table 2016 United States Companion Diagnostics Revenue Share by Manufacturers
Table United States Market Companion Diagnostics Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Companion Diagnostics Average Price of Key Manufacturers in 2015
Figure Companion Diagnostics Market Share of Top 3 Manufacturers
Figure Companion Diagnostics Market Share of Top 5 Manufacturers
Table United States Companion Diagnostics Sales by Type (2011-2016)
Table United States Companion Diagnostics Sales Share by Type (2011-2016)
Figure United States Companion Diagnostics Sales Market Share by Type in 2015
Table United States Companion Diagnostics Revenue and Market Share by Type (2011-2016)
Table United States Companion Diagnostics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Companion Diagnostics by Type (2011-2016)
Table United States Companion Diagnostics Price by Type (2011-2016)
Figure United States Companion Diagnostics Sales Growth Rate by Type (2011-2016)
Table United States Companion Diagnostics Sales by Application (2011-2016)
Table United States Companion Diagnostics Sales Market Share by Application (2011-2016)
Figure United States Companion Diagnostics Sales Market Share by Application in 2015
Table United States Companion Diagnostics Sales Growth Rate by Application (2011-2016)
Figure United States Companion Diagnostics Sales Growth Rate by Application (2011-2016)
Table Roche Diagnostics (Switzerland) Basic Information List
Table Roche Diagnostics (Switzerland) Companion Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Diagnostics (Switzerland) Companion Diagnostics Sales Market Share (2011-2016)
Table Abbott Laboratories (U.S.) Basic Information List
Table Abbott Laboratories (U.S.) Companion Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories (U.S.) Companion Diagnostics Sales Market Share (2011-2016)
Table Agilent Technologies (U.S. Basic Information List
Table Agilent Technologies (U.S. Companion Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies (U.S. Companion Diagnostics Sales Market Share (2011-2016)
Table QIAGEN N.V. (Netherlands) Basic Information List
Table QIAGEN N.V. (Netherlands) Companion Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)
Table QIAGEN N.V. (Netherlands) Companion Diagnostics Sales Market Share (2011-2016)
Table Thermo Fisher Scientific Inc. (U.S. Basic Information List
Table Thermo Fisher Scientific Inc. (U.S. Companion Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Thermo Fisher Scientific Inc. (U.S. Companion Diagnostics Sales Market Share (2011-2016)
Table Myriad Genetics Inc. (U.S.) Basic Information List
Table Myriad Genetics Inc. (U.S.) Companion Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Myriad Genetics Inc. (U.S.) Companion Diagnostics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Companion Diagnostics
Figure Manufacturing Process Analysis of Companion Diagnostics
Figure Companion Diagnostics Industrial Chain Analysis
Table Raw Materials Sources of Companion Diagnostics Major Manufacturers in 2015
Table Major Buyers of Companion Diagnostics
Table Distributors/Traders List
Figure United States Companion Diagnostics Production and Growth Rate Forecast (2016-2021)
Figure United States Companion Diagnostics Revenue and Growth Rate Forecast (2016-2021)
Table United States Companion Diagnostics Production Forecast by Type (2016-2021)
Table United States Companion Diagnostics Consumption Forecast by Application (2016-2021)